Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2009
Hepatitis E virus in patients with unexplained hepatitis in Finland.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kantala Tuija, Maunula Leena, von Bonsdorff Carl-Henrik, Peltomaa Jaakko, Lappalainen Maija
Аннотация
BACKGROUND: Hepatitis E virus (HEV) is an important cause of enterically transmitted viral hepatitis, especially in developing countries. Recently, HEV isolates have been identified in humans also in industrialized countries, where it has been considered nonendemic.
OBJECTIVES: To investigate whether HEV is a cause of unexplained hepatitis in humans in Finland.
STUDY DESIGN: The prevalence of anti-HEV IgM and IgG and HEV RNA was determined in 105 serum samples from 97 patients diagnosed with acute unexplained hepatitis. Partial nucleotide sequences of the HEV isolates obtained were compared with reported sequences in GenBank.
RESULTS: Anti-HEV IgM and/or IgG by both ELISA test and immunoblotting were detected in 29 serum samples (27.6%) from 22 patients (22.7%). HEV RNA was detected in eight patient samples (8.2%) and partial nucleotide sequences were present in five of these. All five viruses belonged to HEV genotype 1, and three of them were from patients who had traveled to Asia.
CONCLUSION: These preliminary results indicate that HEV must be considered a possible cause of acute hepatitis in Finland.
OBJECTIVES: To investigate whether HEV is a cause of unexplained hepatitis in humans in Finland.
STUDY DESIGN: The prevalence of anti-HEV IgM and IgG and HEV RNA was determined in 105 serum samples from 97 patients diagnosed with acute unexplained hepatitis. Partial nucleotide sequences of the HEV isolates obtained were compared with reported sequences in GenBank.
RESULTS: Anti-HEV IgM and/or IgG by both ELISA test and immunoblotting were detected in 29 serum samples (27.6%) from 22 patients (22.7%). HEV RNA was detected in eight patient samples (8.2%) and partial nucleotide sequences were present in five of these. All five viruses belonged to HEV genotype 1, and three of them were from patients who had traveled to Asia.
CONCLUSION: These preliminary results indicate that HEV must be considered a possible cause of acute hepatitis in Finland.